You are Here : Moneycontrol Live TV CNBC TV18 Latest Videos DRL launches Renvela generic in US, price target at Rs 2200: HDFC Securities

Tuesday, 09:16

The pharma major Dr Reddys Laboratories (DRL) has launched kidney disease drug Renvela generic in the US market. How big an opportunity can this be for DRL and what does it do to Aurobindo Pharma. In an interview to CNBC-TV18, Amey Chalke of HDFC Securities shared his views and readings on the same.
FEB 25, 2018
08:55 AM

cnbc tv18 shows

All Shows

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Follow us on
Available On